Kaplan–Meier analysis showed that patients with PD-L1- macrophages nearer to tumor cells during the combination treatment had better OS (p = 0.018, Figure 3I) and PFS (p = 0.013, Figure 3J). This evidence concerns the gene CD274 and neoplasm.